Call it digital health or mHealth or simply what it is — innovation. Last year we saw a lot of innovative wireless devices for diagnostics and treatment as research and development flourished. Many researchers have taken up the challenge of developing devices that are portable, small and convenient with ease-of-use that could revolutionize point-of-care diagnostics […]
9 diabetes breakthroughs you need to know
Diabetes is a disease that affects the body’s ability to produce and respond to insulin. About 29.1 million people have diabetes in the U.S, according to the Centers for Disease Control and Prevention. Of that number, 8.1 million go undiagnosed. One of the most popular breakthroughs in diabetes research has been the artificial pancreas, which […]
Artificial pancreas: These companies are racing to make one
Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at MassDevice’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out our recent […]
This contact lenses breakthrough could enable glucose monitoring
Biosensing contact lenses may not be able to self-heal like “The Terminator,” but they could measure blood glucose and detect other signs of disease in the future. Oregon State University researchers are set to present a study that suggests transparent biosensors that are embedded into contact lenses could provide insight for doctors and patients without […]
MedCrypt and QuiO partner to protect devices from cyberattacks
MedCrypt and QuiO have announced an integration partnership for a set of cloud-connected injection devices known as the Smartinjector devices to provide safe data transfers of patient prescriptions and injections. OuiO will receive software security with this partnership for its Si One, for specialty drugs, and Si Pen, for diabetes patients. MedCrypt’s software will be able to sync […]
Continuous glucose monitoring lowers blood sugar, Swedish study says
A new study from the Sahlgrenska Academy at the University of Gothenburg in Sweden has shown that there was a significant decrease in blood sugar levels and an increased well-being for people with type 1 diabetes over time with the use of a continuous glucose monitor. The study included 161 people with an average age […]
Researchers develop responsive, insulin-releasing skin patch
Researchers from the University of North Carolina at Chapel Hill, North Carolina State University and Changchun Institute of Applied Chemistry at the Chinese Academy of Sciences have developed a skin patch that measures blood glucose levels and releases insulin when levels climb too high. The team’s work testing the patch in mice was published earlier this month […]
University of Virginia has a smartphone-controlled artificial pancreas
Danielle Kirsh, MDO Assistant Editor University of Virginia researchers are making strides when it comes to developing an artificial pancreas that can be controlled using a smartphone. The FDA approved the UVA-developed artificial pancreas for testing in 2012, and UVA received a $3.4M grant from the National Institutes of Health in 2013. The device is currently […]
Diabetes: Glooko adds Dexcom, Insulet to platform
Glooko said yesterday that it inked deals with Dexcom (NSDQ:DXCM) and Insulet (NSDQ:PODD) to supply device data from both companies to its diabetes management platform. Glooko’s platform will now integrate Dexcom’s continuous glucose monitoring systems and Insulet’s OmniPod insulin management systems in a new version of the platform that’s slated for a summer release, the Palo Alto, Calif.-based company […]
Diabetes: Eli Lilly gets in on $3m round for Companion Medical
Companion Medical said it raised $3.2 million of a hoped for $3.5 million in a Series B round from 3 investors, including pharmaceutical company Eli Lilly (NYSE:LLY). San Diego-based Companion Medical said the funds are slated to help pursue FDA 510(k) clearance for its Bluetooth-enabled insulin pen and connected smartphone app. “Lilly is focused on delivering […]
UPDATE – Insulin pump hacker outs Medtronic, company responds
The security expert who hacked his own insulin pump revealed that the device came from Medtronic Inc. (NYSE:MDT), and accused the med-tech giant of ignoring his warnings.
Today the Natick, Mass.-based med-tech giant posted its official response to the hullabaloo, writing that it takes device information security very seriously but sees malicious medical device hacking as a very low threat.
